Summary. Glucagon-like peptide-1 and glucagon-like peptide-2 are encoded by the m-RNA of pancreatic preproglucagon. They show high conservation in different species and substantial sequence homology to glucagon. Because no definite biological activity of these peptides has been reported, we investigated the effect of synthetic C-terminally amidated glucagon-like peptide-t [1-36] and synthetic human glucagonlike peptide-2 [1-34] with a free C-terminus on insulin release from isolated precultured rat pancreatic islets in the presence of glucose. Glucagon-like peptide-1 stimulates insulin release at 10 and 16.7 mmol/1 glucose in a dose-dependent manner. Significant stimulation starts at 2.5 nmol/1 in the presence of 10 mmol/1 glucose and near maximal release is observed at 250 nmol/l, with approximately 100% increase over basal at both glucose concentrations. The peptide reaches 63% of the maximal stimulatory effect of glucagon. No stimulation occurs in the presence of 2.8 mmol/1 glucose. Glucagon-like peptide-2 has no effect on insulin secretion at any glucose concentration tested. It is concluded that glucagon-like peptide-t, in contrast to glucagon-like peptide-2, exhibits a glucose-dependent insulinotropic action on isolated rat pancreatic islets similar to that of glucagon and gastric inhibitory polypeptide.Key words: Glucagon-like peptide-t, glucagon-like peptide-2, insulin release, glucose dependency, isolated islets.Pancreatic preproglucagon m-RNA, the precursor of pancreatic glucagon, has been cloned and sequenced from different species using recombinant DNA-techniques [1][2][3][4][5]. Two other peptides have been found arranged in tandem on the same m-RNA in close proximity C-terminal to the glucagon precursor: glucagonlike peptide-I (GLP-1) and glucagon-like peptide-2 (GLP-2) comprising 36 and 34 amino acid residues, respectively. Both peptides show a different degree of sequence homology to pancreatic glucagon. The GLP-1 sequence is identical in the human, bovine and hamster precursor, whereas minor differences exist between the corresponding GLP-2 sequences. This substantial conservation in evolution and the close sequence homology to the glucagon molecule (GLP-I: 48% identical residues; GLP-2: 38%) indicates that GLP-1 and GLP-2 may play an important role of their own as hormones or local modulators. Recently they have been detected by specific radioimmunoassays in glucagonomas and in rat pancreatic islets [6], although they have not to date been isolated at the peptide level. Very little is known about a specific biological activity of these peptides. Hoosein and Gurd [7] could demonstrate a potent stimulation of rat hypothalamic and pituitary adenylate cyclase, whereas binding of glucagon to rat brain and liver membranes was not inhibited. GLP-1 may exert a weak stimulatory effect on exocrine pancreatic secretion in the rat [8].Suggesting a role in carbohydrate metabolism, we investigated the effect of synthetic GLP-I and GLP-2 on insulin release from isolated precultured rat pancreatic islets in th...